These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21995270)

  • 1. Aplasia cutis congenita and other anomalies associated with methimazole exposure during pregnancy.
    Rodríguez-García C; González-Hernández S; Hernández-Martín A; Pérez-Robayna N; Sánchez R; Torrelo A
    Pediatr Dermatol; 2011; 28(6):743-745. PubMed ID: 21995270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aplasia cutis congenita after exposure to methimazole: a causal relationship?
    Vogt T; Stolz W; Landthaler M
    Br J Dermatol; 1995 Dec; 133(6):994-6. PubMed ID: 8547058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aplasia cutis congenita after methimazole exposure in utero successfully treated with basic fibroblast growth factor.
    Abe M; Syuto T; Yokoyama Y; Ishikawa O
    Int J Dermatol; 2010 Mar; 49(3):334-5. PubMed ID: 20465676
    [No Abstract]   [Full Text] [Related]  

  • 4. Aplasia cutis congenita following in utero methimazole exposure.
    Baid SK; Merke DP
    J Pediatr Endocrinol Metab; 2007 May; 20(5):585-6. PubMed ID: 17642418
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aplasia cutis congenita and antithyroid drugs during pregnancy: Case series and literature review].
    Sachs C; Tebacher-Alt M; Mark M; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2016; 143(6-7):423-35. PubMed ID: 27033749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aplasia cutis congenita after methimazole exposure in utero.
    Karg E; Bereg E; Gaspar L; Katona M; Turi S
    Pediatr Dermatol; 2004; 21(4):491-4. PubMed ID: 15283799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero.
    Iwayama H; Hosono H; Yamamoto H; Oshiro M; Ueda N
    Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):680-4. PubMed ID: 17803201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aplasia cutis congenita due to methimazol exposure within the first trimester of pregnancy: case report.
    Akar M; Dilli D; Sandal G; Erdeve Ö; Dilmen U
    J Perinat Med; 2011 Nov; 39(6):743-4. PubMed ID: 21809898
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
    Bowman P; Osborne NJ; Sturley R; Vaidya B
    QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aplasia cutis congenita and skull defects after exposure to methimazole in utero.
    Nakamura S; Nishikawa T; Isaji M; Ishimori M; Shimizu N; Iwamura M; Nishikawa Y; Kubo M; Totani R
    Intern Med; 2005 Nov; 44(11):1202-3. PubMed ID: 16357464
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of aplasia cutis congenita following in utero exposure to carbimazole].
    Kojmane W; Atmani S
    Ann Dermatol Venereol; 2020 Jan; 147(1):76-77. PubMed ID: 31818499
    [No Abstract]   [Full Text] [Related]  

  • 13. Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero.
    Löllgen RM; Calza AM; Schwitzgebel VM; Pfister RE
    J Pediatr Endocrinol Metab; 2011; 24(3-4):215-8. PubMed ID: 21648296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of aplasia cutis congenita with therapy of maternal thyroid disease.
    Kalb RE; Grossman ME
    Pediatr Dermatol; 1986 Sep; 3(4):327-30. PubMed ID: 3774652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aplasia cutis as a teratogenic effect of methimazole].
    Díez-Delgado Rubio J; Belmonte Martín MJ; Calvo Bonachera MD; López Candel E
    An Esp Pediatr; 1999 Sep; 51(3):290-2. PubMed ID: 10575754
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antithyroid agents and embryopathies].
    Bournaud C; Orgiazzi J
    Ann Endocrinol (Paris); 2003 Nov; 64(5 Pt 1):366-9. PubMed ID: 15067747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
    Mandel SJ; Brent GA; Larsen PR
    Thyroid; 1994; 4(1):129-33. PubMed ID: 7519913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Syndrome of arthritis by antithyroid drugs].
    Martín Marco A; Boquet Estruch D
    Med Clin (Barc); 2003 Mar; 120(11):436-7. PubMed ID: 12681226
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure.
    Macia M; Méndez M; Fernández J; Riverol A; Rios
    Clin Nephrol; 1997 Feb; 47(2):129. PubMed ID: 9049463
    [No Abstract]   [Full Text] [Related]  

  • 20. Aplasia cutis congenita of the scalp: therapeutic modalities.
    Shivakumar SK; Dwarakanath S; Swaroop G; Venkataramana NK
    Neurol India; 2006 Sep; 54(3):312-3. PubMed ID: 16936401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.